Fig 1.
Flowchart of the 130 patients included in the study.
Table 1.
Definition of periprosthetic hip joint infections in the 130 identified patients.
Table 2.
Microorganism cultured in 130 patients treated for chronic hip PJI between 2003 and 2008.
Table 3.
Baseline demographics of 130 patients treated for chronic hip Periprosthetic Joint Infection between 2003 and 2008.
Fig 2.
Cumulative incidence curve on re-infection after treatment for chronic periprosthetic hip joint infection in 81 patients undergoing re-implantation following a two-stage revision strategy in the presence of competing events, death and open aseptic revision.
Fig 3.
Survival curve after treatment for chronic periprosthetic hip joint infection in 130 patients (upper). Survival curves after treatment for chronic periprosthetic hip joint infection in 81 patients undergoing re-implantation following a two-stage revision strategy and 48 patients not undergoing re-implantation following a two-stage revision strategy (lower).
Table 4.
Cox regression model fitted on selected predictive variables for assessment of influence on survival regardless of treatment received in 130 patients treated for chronic hip PJI between 2003 and 2008.